Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

BUY
$84.7 - $96.31 $1.06 Million - $1.2 Million
12,510 New
12,510 $13,000
Q2 2020

Aug 13, 2020

SELL
$34.32 - $62.43 $24,092 - $43,825
-702 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$32.64 - $73.63 $22,913 - $51,688
702 New
702 $28,000
Q4 2019

Feb 14, 2020

SELL
$48.0 - $59.55 $366,336 - $454,485
-7,632 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$46.64 - $55.39 $466,400 - $553,900
-10,000 Reduced 56.72%
7,632 $406,000
Q2 2019

Aug 12, 2019

SELL
$40.81 - $52.42 $351,578 - $451,598
-8,615 Reduced 32.82%
17,632 $901,000
Q1 2019

May 15, 2019

SELL
$36.91 - $55.7 $396,893 - $598,942
-10,753 Reduced 29.06%
26,247 $1.36 Million
Q4 2018

Feb 13, 2019

BUY
$36.49 - $51.72 $1.35 Million - $1.91 Million
37,000 New
37,000 $1.46 Million

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Fortis Advisors, LLC Portfolio

Follow Fortis Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortis Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortis Advisors, LLC with notifications on news.